Matthew Binnicker

Matthew Binnicker is a health and science journalist who covers public health and medical topics with a focus on misinformation and the impact of various viruses. He has reported extensively on Covid-19, including its variants, vaccine developments, and the role of vaccines in controlling the pandemic. Binnicker's work often highlights potential conflicts of interest and deceptive practices in reporting about public health issues. His articles are published in Forbes, where he shares primary insights into the rising temperatures and Covid-19 cases as well as other infectious diseases like avian influenza.

Biography:  https://www.forbes.com/sites/matthewbinnicker/

78%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

75%

Examples:

  • Matthew Binnicker frequently reports on public health and medical topics with a focus on misinformation and the impact of various viruses.

Conflicts of Interest

80%

Examples:

  • Binnicker frequently reports on Covid-19 without disclosing potential conflicts of interest related to his sources or affiliations.

Contradictions

85%

Examples:

  • In an article about Covid-19 variants, Binnicker states that an updated vaccine targeting the JN.1 lineage and KP.2 subvariant will be available this fall, despite the ongoing surge in cases.

Deceptions

75%

Examples:

  • Binnicker also misleads readers by stating that these subvariants possess several mutations in the gene encoding for the spike protein, which is targeted by antibodies generated by Covid-19 vaccines.
  • In an article about the rise in summer temperatures and Covid-19 cases, Binnicker suggests that there are steps people can take to prevent the spread of the virus, despite the emergence of new subvariants.

Recent Articles

New COVID-19 Subvariants KP.3, KP.2, and LB.1: Evading the Immune System and Surge in Cases During Summer Months

New COVID-19 Subvariants KP.3, KP.2, and LB.1: Evading the Immune System and Surge in Cases During Summer Months

Broke On: Wednesday, 26 June 2024 New COVID-19 subvariants KP.3, KP.2, and LB.1 are on the rise during summer months, causing an increase in cases due to their ability to evade the immune system effectively. Vulnerable populations are at higher risk for severe disease but vaccination remains the best defense against infection and severe illness as new vaccine formulations targeting these subvariants become available this fall.